How NIH Study Sections Work: Scoring, Percentiles, and Paylines Explained

Your NIH grant was just assigned to a study section. You know that five reviewers will read it. You know that somewhere in the next four months you will get a priority score and a percentile. But what happens in that study section — how reviewers actually evaluate your work, what the numbers mean, and why the payline matters — often remains opaque until you read your summary statement in shock.

The NIH's Simplified Peer Review Framework, introduced for due dates on and after 25 January 2025, is the first major change to the review process in a decade. If you submitted before that date, your application was reviewed under the five-criteria system (Significance, Innovation, Approach, Investigator, Environment). If you submit now or later, you are in the new framework: three factors, a 1–9 scale, and a percentile ranking that is more granular and more transparent than the old system. This post decodes how the new process works — what reviewers are looking for, how scores become percentiles, why paylines vary, and how to read the summary statement that comes back.

What is a study section, and why does yours matter?

A study section is a standing committee at the NIH's Center for Scientific Review (CSR) — typically 25 to 30 reviewers who meet two or three times per year. Each reviewer is a working scientist, usually a faculty member or principal investigator, drawn from the field covered by the study section. An RCN study section, for example, focuses on research training and capacity building; an STTR study section handles small business research.

Study sections are the first gate in NIH peer review. Your application goes through CSR assignment, which routes it to the study section that the CSR office believes is the best fit. The study section is where your application gets its first substantive evaluation, and where the summary statement — the document you will eventually read — gets written. It is also where most applications that will never be funded are identified and streamlined (discussed below).

Standing sections vs. Special Emphasis Panels

Standing study sections meet regularly and have consistent membership. They cover the full range of NIH science. Special Emphasis Panels (SEPs) are convened on an ad-hoc basis to review applications in emerging areas or to handle temporary surges in a particular grant mechanism. Both follow the same review process, but standing sections have institutional memory and reviewers who know each other's standards.

How to suggest a study section

You can suggest a study section in your application cover letter. The CSR takes these suggestions seriously, particularly if you explain why that study section is the right home for your science. A good suggestion — one that demonstrates that you understand both your research and the study section's scope — can improve the quality of review you receive. The assignment office will not always honour the suggestion if CSR staff believe another section is more appropriate, but the request is noted and considered.

Never suggest a study section as a strategic move to find "easier" reviewers. The NIH's assignment staff are experienced and will catch obvious gaming. Suggest a study section because it is genuinely the best fit, and the reviewer pool will be more expert and fair.

The Simplified Peer Review Framework: Factor 1 (Importance of the Research)

Under the framework introduced 25 January 2025, your application is evaluated on three factors, each with a score of 1–9 (with 1 = exceptional, 2 = excellent, through 9 = poor). The first is Importance of the Research, which combines what the old system called Significance and Innovation into one criterion.

What reviewers are looking for in Factor 1

Reviewers ask: Does this research address a significant problem? Is the question important? Is the approach innovative — does it break new ground, or does it apply existing methods to a known problem? A study that applies an established tool to a new population can be significant without being innovative; a study that introduces a new method to an old problem can be innovative without yet knowing whether it will yield significant results. You need to make both cases in your Specific Aims and Research Strategy. The aim is not to hype the impact but to show, with evidence, why the answer matters — to the field, to patients, to fundamental knowledge.

Reviewers in 2026 are also reading with Google March 2026 core update in mind, which means they are scrutinising claims of novelty. If you claim "no one has done this before," be prepared to defend it with a thorough literature review. If you claim "this applies an existing method to a new context," name the context and why it has not been studied before. Confidence and precision together signal rigour.

Factor 1 red flags that lower your score

A high (poor) Factor 1 score typically reflects one or more of the following: the question is too incremental to justify the resources required; the innovation is oversold or not clearly distinguished from prior work; the significance is claimed but not demonstrated; or the research does not address a gap that reviewers recognise as important. The review summary will tell you which.

The Simplified Peer Review Framework: Factor 2 (Rigor and Feasibility)

Factor 2 combines the old Approach criterion with a feasibility assessment. Reviewers ask: Is the study design sound? Are the methods appropriate to the question? Is the project actually doable within the proposed timeframe and budget, and with the proposed team?

What reviewers are looking for in Factor 2

Reviewers want to see a Research Strategy that is methodologically rigorous and honest about limitations. You need to specify your hypotheses or aims clearly; defend your methods with citations and preliminary data; describe your statistical approach (power calculations, multiple-comparison corrections, how you will handle missing data); and explain how you will know whether you have succeeded or failed. For an R01, reviewers expect a detailed timeline showing that the work is feasible in five years. For shorter grants (R21, R03), feasibility is tighter and more scrutinised.

The feasibility part is often underestimated. You can have a brilliant research design and still receive a poor Factor 2 score if reviewers question whether you have the infrastructure, the resources, or the time to execute it. If you are proposing to collect samples from five sites, name the sites, confirm letters of support, and show that your team has experience coordinating across them. If you are proposing a novel computational analysis, show that you have preliminary results or access to a collaborator who has done this before. Feasibility is not pessimism; it is credibility.

Factor 2 red flags that lower your score

Poor Factor 2 scores reflect unclear hypotheses, weak justification for methods, missing or preliminary power calculations, vague timelines, unaddressed ethical concerns, or concern that the applicant has overcommitted (too much time allocated to other projects or service roles). The summary statement will specify which.

The Simplified Peer Review Framework: Factor 3 (Expertise and Resources)

Factor 3 is different from Factors 1 and 2: it is not scored on the 1–9 scale. Instead, reviewers give it a binary rating: sufficient or not sufficient. This shift is significant because it de-emphasises the "prestige" criterion (your CV, your pedigree, your previous NIH funding) in favour of a practical assessment: do you and your team have the expertise and resources required to do this specific project?

What "sufficient expertise and resources" means

Sufficient does not mean exceptional. A new investigator with strong methods training and access to a field site has sufficient expertise. An established PI with weak collaborators but full institutional support has sufficient expertise. The question is specific and bounded: for this project, is the expertise adequate and are the resources available?

Resources include your institutional environment — library access, computing infrastructure, animal care facilities, cores, mentoring — as well as the key personnel you have listed. If you are proposing to work with human subjects, describe your IRB track record or your mentor's. If you are proposing to do bioinformatics, show that you have access to computing and that someone on the team has done this analysis before (even in a different context).

When Factor 3 becomes "not sufficient"

A "not sufficient" rating is rare but serious. It typically means reviewers have identified a gap that cannot be bridged within the proposed project — for example, you are proposing an expensive clinical trial but your institution has never run one; or you are proposing single-lab work but you are a research scientist without independent space; or you list a key collaborator who is now at another institution without a letter of support confirming the new arrangement. A not sufficient Factor 3 score is a screen-out, regardless of how strong your Factors 1 and 2 are. A resubmission addressing the specific gap is often successful.

From scores to priority score to percentile: how the numbers work

Here is the mechanics of how your score happens. You get assigned five reviewers — call them Reviewers A, B, C, D, and E. Each reviews your application independently on the three factors. For Factors 1 and 2, each reviewer gives you a score from 1 to 9. For Factor 3, each reviewer says sufficient or not sufficient (or in rare cases, defers the assessment if data in the summary statement will inform it).

Priority score calculation

If all five reviewers rate Factor 3 as sufficient, your priority score is calculated as follows:

Priority score = ((Sum of all Factor 1 scores + Sum of all Factor 2 scores) / 10) × 10

This means the average of all Factor 1 and 2 scores from all reviewers, multiplied by 10 to scale to a 10–90 range. A score of 10 is exceptional (all reviewers gave you 1s); a score of 90 is poor (all reviewers gave you 9s). Most funded applications cluster between 10 and 35.

If one or more reviewers rate Factor 3 as not sufficient, your application receives no priority score and is not percentiled. It is returned unfunded with the option to revise and resubmit.

Percentile ranking: where you stand in the study section

Your percentile ranks your priority score against all other applications reviewed in your study section in the same funding cycle. If your study section reviewed 80 applications and your priority score puts you in the top 8 (best 10 percent), your percentile is 10. If you are ranked 40th out of 80, your percentile is 50. A lower percentile is better.

Percentiles are study-section-specific. You might be the 20th percentile in one study section and the 35th in another because the applicant pools have different characteristics. This is why study section assignment can matter — not in terms of review quality, but in terms of who you are competing against.

What about streamlined applications?

Approximately 50 percent of applications in a study section are identified as streamlined — meaning they score in the bottom half and are not discussed at the full committee meeting. These applications still receive a priority score and percentile, and still go to the program officer and the institute's grant awarding group. But the reduced discussion can result in less detailed feedback in the summary statement. A streamlined score is not a rejection and does not disqualify a resubmission. Many strong resubmissions begin as streamlined applications.

From priority score to payline: how funding happens

Your priority score and percentile determine whether your application is invited to the payline conversation, but the payline itself determines whether it is actually funded. This is where the process becomes institute-specific.

What is a payline?

A payline is the percentile rank below which an institute will commit to fund all applications (absent a binding conflict of interest). Each of the 27 NIH institutes and centers sets its own payline, usually after the fiscal year budget is announced. An institute with a large budget and a streamlined review load might set its R01 payline at the 20th percentile (meaning all R01s ranked 20 or better get funded). An institute with a tighter budget might set it at the 10th percentile. The payline varies by grant mechanism — R01, R21, R03 — and sometimes by targeted areas.

In the current funding climate, most R01 paylines hover between the 10th and 20th percentile. The fact that the overall NIH R01 success rate is 13.0 percent (FY2025) means that on average, across all institutes, you need to be better than about the 13th percentile to be funded.

The grey zone: above payline but potentially fundable

Applications that score above the payline (worse than the payline percentile) are not automatically rejected. They move into the grey zone, where the program officer and institute director have discretion to recommend funding based on strategic priorities, emerging areas, or portfolio balance. An application at the 25th percentile in an institute with a 20th percentile payline is still in contention if the program officer believes it addresses a priority gap. But you cannot count on it.

What to do if you are above the payline

Contact the program officer assigned to your study section (the CSR will tell you who) and ask for feedback on why your application scored as it did, and whether the institute has discretionary funding. Program officers are candid if you ask directly. If the feedback suggests the problem is feasibility or expertise (Factor 2 or 3), a resubmission has good odds. If the feedback is that the science is not a priority fit for the institute, consider resubmitting to a different institute, or pivoting the research question to align better with the institute's mission.

Reading your summary statement: finding the real feedback

Your summary statement will arrive 2–4 weeks after the study section meeting. It contains a critique from each reviewer, plus a summary written by the study section chair. You will be tempted to read it as a referendum on you and your science. It is not. It is a road map for the resubmission — if you choose to resubmit.

What each section of the summary statement tells you

Strengths: This is usually short. It lists what reviewers thought was good about the application. These are not things to drop in a resubmission; these are things to build on or clarify further if reviewers missed the point.

Weaknesses: This is the actionable section. If two or more reviewers raise the same concern, it is a threshold issue. If only one reviewer raised it, it may be a stylistic preference or a misunderstanding that you can clarify without restructuring the project. Read for consensus, not for exceptions.

Study section discussion summary: This paragraph, written by the chair, synthesises the discussion. It often contains nuance that the individual critiques do not — for example, "the study design is sound, but reviewers were concerned about recruitment timelines." Use this to prioritise your resubmission strategy.

How to tell if a comment is a real concern or a stylistic note

Real concerns appear multiple times, in different reviewers' critiques, and are emphasised in the chair's summary. A comment raised by one reviewer in parentheses is probably a minor note. A comment that appears in three reviewers' critiques and gets a sentence in the summary is a blocker that you must address.

If a reviewer misunderstood your application (for example, they thought you were proposing an intervention when you were proposing a measurement), you can clarify it in the resubmission. But if three reviewers misunderstood, the problem is probably your writing. Rewrite for clarity, do not assume reviewers failed to read.

Study section assignment and the cover letter strategy

The CSR assignment office reads thousands of applications. When you suggest a study section, you are adding signal to their triage process. Make the suggestion specific. Instead of "Please assign my application to the Environmental Health or Epidemiology study section," write: "This application studies wildfire smoke exposure in pregnancy and respiratory outcomes. I suggest review by the Environmental Health study section, which has particular expertise in air quality epidemiology and includes members familiar with cohort recruitment in rural populations." The specificity signals that you know your field and have thought about fit.

If your research falls between study sections — for example, it is methods-focused but clinically motivated — your cover letter is the place to explain why the secondary suggestion matters. "Primary suggestion: Biostatistical Methods and Research Quality. Secondary suggestion: Cardiovascular Study Section, given the specific application to atrial fibrillation screening." This gives the assignment office useful information without trying to game the system.

Contacting programme officers before and after the review

Programme officers are assigned to each institute's scientific portfolio. They attend study section meetings (though they do not vote) and advise on which applications get funded above the payline. Contacting one before you submit is not a violation; it is expected. A pre-submission call or email — "I am submitting an R01 on X. My primary program officer is [name]. I wanted to confirm this is a good fit for the institute" — can save you from a mismatch. Programme officers can tell you if your topic is a strategic priority, if there are ongoing funding constraints, or if a related RFP is coming soon.

After the review, if you are above the payline, contact your programme officer to ask what happened. "We received a percentile of 25, above the payline. What can you tell me about the feedback, and is there discretionary funding?" Programme officers are bound by certain confidentiality rules, but they can tell you whether the institute is interested in the work and whether a resubmission makes sense.

Never ask a programme officer to override a study section's decision or to pressure reviewers. Programme officers can only advise and fund within the payline. But they can tell you the truth, and that is what you need to decide whether to revise and resubmit.

Choosing the right grant mechanism for your study section

Different grant mechanisms (R01, R21, R03) are designed for different types of research and are reviewed separately within each study section. An R01 is for established research programmes; reviewers expect five years of detailed planning and preliminary data across all aims. An R21 is for exploratory work; reviewers expect a shorter timeline, higher risk, and less preliminary data — but feasibility still matters. An R03 is for limited-scope projects and costs approximately $50,000 per year.

Choose the mechanism that fits your work, not the one with the highest success rate. Submitting exploratory research as an R01 will score poorly on feasibility. Submitting established research as an R21 will be rejected for lacking the depth and preliminary data expected of an R01. Your study section has seen thousands of applications; they know which mechanism fits which project.

Early Stage Investigator (ESI) and New Investigator status

ESI status (defined by the NIH; broadly, PIs within 10 years of terminal degree with no prior R01 award) can qualify you for set-aside funds at some institutes, but it does not give you a lower payline or easier review. New Investigator status alone is not a programmatic category, but some institutes track it. If you are an ESI, it will appear on your face page and reviewers will see it. Use your cover letter to explain how it is relevant — "As an ESI establishing my independent research programme, this R01 represents..." — if it matters to your study section assignment strategy.

Checklist: Study section strategy before you submit

The real payoff

Understanding the NIH peer review process is not about gaming it or finding loopholes. It is about clarity. When you know that a study section of 25 reviewers will be assigned your application and that five of them will read it in detail, you write for them — specific, methodical, honest. When you know that your priority score is an average and that percentiles rank you against competitors, you understand that your job is not to write a perfect application; it is to write a better one than 85 percent of the pool in your study section that cycle. When you know what the programme officer can and cannot tell you, you ask the right questions and use their feedback to make a smart resubmission decision. Those are the moves that work.